COPIED
mins

WOMEN’S HEALTH

TESTOSTERONE TRUTH

Dr Ginni Mansberg examines what science says about testosterone and the skin, separating evidence from trends

TESTOSTERONE AND THE SKIN

Skin is not a passive bystander in androgen biology. It contains androgen receptors across multiple cell types including fibroblasts, keratinocytes, and sebaceous gland cells, and actively metabolises testosterone and DHT.1

The most clinically visible effect of androgens in skin is on the sebaceous glands. Testosterone and DHT stimulate sebaceous gland proliferation and sebum secretion, which is why puberty brings increased skin oiliness and acne in the majority of adolescents.2 This relationship is dose-dependent and receptor-mediated.2

The relationship with collagen is more nuanced. At a cellular level, androgens can stimulate fibroblast activity and collagen I production in vitro.3 However, in vivo wound-healing data suggest that androgens may impair cutaneous repair. Ashcroft and colleagues demonstrated that testosterone delays wound healing by prolonging the inflammatory phase and impairing collagen deposition in the wound bed.4 These contradictory findings likely reflect the complexity of androgen signalling, with effects differing according to tissue state, local hormonal milieu, and whether the primary driver is testosterone or its conversion products.

Skin thickness is greater in men than women, correlating with androgen exposure, though oestrogen and growth hormones. Male skin has a thicker dermis and higher collagen density than female skin, differences that appear to be partly androgen-dependent.3

DECLINING TESTOSTERONE

Whether declining testosterone has clinically meaningful skin effects is mostly unknown. In men, the skin changes attributed to the gradual decline in testosterone with age include reduced dermal thickness and altered sebum production, though distinguishing androgen effects from the concurrent decline in growth hormone and IGF-1 is challenging.3

In women, the evidence that declining female testosterone independently causes skin ageing is limited, and the Endocrine Society and other major bodies have not endorsed testosterone for skin-related indications in women.4

Some data suggest androgens may contribute to maintaining skin thickness. Brincat et al. found a 48% increase in skin collagen content in women treated with combined oestradiol and testosterone for two to ten years compared with untreated controls, though whether the benefit was attributable to testosterone, oestradiol, or the combination remains unclear.6

SYSTEMIC TESTOSTERONE THERAPY

For men, a 2026 scoping review published in Sexual Medicine Reviews synthesised findings from 10 studies on the dermatological effects of TRT.7 The findings were sobering for those hoping for a cosmetic dividend: acne was the most common skin-related adverse effect, affecting 0.6–9.1% of participants, with the highest rates in injectable formulations. Pruritus, rash, and abnormal hair growth were also reported.8 The review found no studies reporting skin rejuvenation or anti-ageing outcomes as a primary endpoint.

For women, the picture is similarly dominated by adverse effects rather than benefits. Acne and hirsutism are the most frequently reported cutaneous side effects, though at female-appropriate doses the risk is considerably lower than in supraphysiological use.4 The Endocrine Society 2019 position statement endorses testosterone therapy in post-menopausal women only for hypoactive sexual desire disorder and notes the absence of safety and efficacy data for other indications including skin.

In a meta-analysis of 35 studies, 7% of women developed acne and 10.7% hirsutism.8 A few small studies have examined combined oestrogen-testosterone HRT and skin outcomes in post-menopausal women.

These show mixed signals on collagen and skin thickness, are confounded by concurrent oestrogen use, and are uniformly underpowered. None compares testosterone with a retinoid, the established standard of care for skin ageing.6

TOPICAL TESTOSTERONE ON THE FACE

The current social media iteration sees influencers applying prescription testosterone gel to the skin as an anti-ageing intervention. The logic is simple: testosterone thickens skin, stimulates collagen, and firms the face. But the evidence for this is essentially non-existent. The closest data come from gender-affirming hormone therapy studies, which document increased skin oiliness and acne with topical testosterone, not the refined, firmed complexion promised online.7

The risks are meaningful and underdiscussed, ranging from acne, virilisation, facial hair growth, menstrual disruption and voice deepening in women, as well as unintended exposure to children through skin-to-skin contact.9 Testosterone has a genuine and complex relationship with skin biology, but the evidence does not support its use as an anti-ageing treatment.

If a patient has symptoms that might reflect androgen deficiency, Scan for references: appropriate assessment and supervised hormone therapy through a qualified clinician is the correct pathway.

DR GINNI MANSBERG

Dr Ginni Mansberg is a GP, TV presenter, podcaster, author and columnist. She is a physician specialising in women’s health, menopause and all things skin. She is also the co-founder and medical director of science-based cosmeceutical skincare brand, ESK.

This article appears in Jul/Aug 2026

Go to Page View
This article appears in...
Jul/Aug 2026
Go to Page View
DEAR READERS
Welcome to the July/August issue of Aesthetic Medicine Magazine.
MEET THE EXPERTS
The Aesthetic Medicine editorial board’s clinical expertise and diverse range of specialities help ensure the magazine meets the needs of the readers. In this issue, we have received guidance from the following members:
HOT OFF THE PRESS
BCAM warns public over illegal and unregulated peptide injections
OUT & ABOUT
CIRCADIA UK’S MINISTRY OF SKIN 2026 Knebworth House, Stevenage
GETTING TO KNOW DR AHMED EL HOUSSIENY
After beginning his career in one of medicine’s most demanding specialties, Dr Ahmed El Houssieny has built a successful clinic, training academy and reputation as a leading educator in aesthetics. He speaks to editor Kezia Parkins about governance, business, education and why caution still matters in a fast-moving sector.
THE RISE OF THE ‘MINI BLEPH’
Dr Richard Devine explains why blepharoplasty is becoming a more mainstream option for patients looking to refresh tired eyes and how he achieves comparable results without surgery.
Case study: COMBINATION REGENERATIVE HAIR RESTORATION
Natalie Clendinning showcases hair restoration outcomes with microneedling, exosomes, and polynucleotide injections.
THE NEW PREVENTION ERA
Anna Dobbie investigates how longevity medicine, advanced diagnostic technology and personalised health strategies are shifting the sector’s focus toward preventative treatments
CUTTING-EDGE CLINICS
From bookings and marketing to reporting and patient communication, AI is helping clinics work smarter, reduce admin and drive growth.
SCALP MATTERS
Why the scalp should be treated with the same clinical seriousness as the skin
IS AI CHANGING THE RISK LANDSCAPE IN AESTHETICS?
AI is changing aesthetics – but responsibility still sits with us, writes Eddie Hooker , founder and CEO of Hamilton Fraser
DOES A FACELIFT REALLY SLIP? SETTING PATIENT EXPECTATIONS FOR THE LONG TERM
Addressing the common patient concern of post-surgical ‘slippage,’ Dr. Roberto Viel explores the realities of tissue settling, the importance of lift vectors, and the strategic maintenance required to ensure long-term rejuvenation.
NOT ALL PRP IS THE SAME
Claudia McGloin explains how to understand leukocyte-rich and leukocyte-poor preparations
TESTOSTERONE TRUTH
Dr Ginni Mansberg examines what science says about testosterone and the skin, separating evidence from trends
THE HUMAN TOUCH
As artificial intelligence becomes more and more embedded in the patient journey, Vicky Eldridge asks, are we losing sight of what really matters in aesthetic practice?
OVER “DONE”
Emma Wedgwood looks at how regenerative treatments are shifting aesthetic medicine away from correction and towards restoring definition, structure and long-term skin health.
MEDICAL-GRADE MYTH
Is “medical-grade” cosmetics a term without definition?
STAYING HUMAN IN AESTHETICS
In an increasingly transactional industry, staying connected to the people behind the treatments has never been more important. Julie Scott reflects on compassion, boundaries and the value of remaining fully present in aesthetic practice.
STANDARDS OR SUGGESTIONS?
Everyone supports high standards, until they become inconvenient. Amy Bird examines why standards without enforcement are simply suggestions
A NO BRAINER FOR AESTHETIC CLINICS
Lisa Kelly explores the practical AI tools that are already helping aesthetic clinics save time, improve efficiency and unlock new revenue opportunities
LEGAL CHECKLIST
Peter Kouwenberg, explains the key legal considerations aesthetic practitioners should address before introducing new services.
HOW SHOULD EVOLVING LASER REGULATIONS IMPACT MY CLINIC’S APPROACH TO SKIN RESURFACING?
How should evolving laser regulations impact my clinic’s approach to skin resurfacing? he regulatory landscape for aesthetic treatments
HOW CAN OMEGA-3 SUPPORT TREATMENT OUTCOMES?
How can omega-3 support treatment outcomes?
THE RELIABLE ONES
Anna Miller answers why the people you depend on most may be carrying more than you realise
AUTHENTIC DESIGN
Does your clinic truly mirror the brand you promote online? Katie Thomas explains why crafting a clinical environment that aligns with your marketing ensures clients get everything they expect – and more
TACKLING PROFESSIONAL ISOLATION IN AESTHETIC MEDICINE
As aesthetic medicine continues to mature, many practitioners still work in relative isolation compared with their colleagues in traditional healthcare settings. Dr Jordan Faulkner argues that stronger professional networks, mentorship and collaborative learning are essential to improving governance, clinician wellbeing and patient safety across the specialty.
ALUMIER MD INTELLIRET BOOST PEEL
Editorial assistant, Connie Cooper tried the new Alumier MD IntelliRET Boost peel within a customised skin peel treatment, addressing breakout prone skin
TEOXANE BABYGLOW AT COSMETIC SKIN CLINIC
Editor Kezia Parkins got the opportunity to try Teoxane’s newest treatment, babyGLOW™, at the Cosmetic Skin Clinic.
PRODUCT NEWS
Medik8 Medik8’s Exo-PDRN Prismatic+ Pro Concentrate is a
5 MINUTES WITH EMILY-LOUISE VARNFIELD
Emily-Louise Varnfield , founder of The Beaute Group , discusses the future of aesthetic technology, the importance of clinical outcomes and the opportunities shaping the industry.
5 tech-forward practitioners to follow
These five practitioners are driving conversations in the increasingly technology driven industry
Ask Alex
“Everyone on TikTok seems to just talk now. Should I be ‘yapping’ too?”
Looking for back issues?
Browse the Archive >

Previous Article Next Article